Chemical and Biological Agent Deny: Selective Phosphate Ester Hydrolysis

Award Information
Agency:
Department of Defense
Amount:
$99,985.00
Program:
SBIR
Contract:
HDTRA1-06-P-0114
Solitcitation Year:
2006
Solicitation Number:
2006.1
Branch:
Defense Threat Reduction Agency
Award Year:
2006
Phase:
Phase I
Agency Tracking Number:
RDI060003702
Solicitation Topic Code:
DTRA06-012
Small Business Information
CALDERA PHARMACEUTICALS, INC.
903 Tewa Loop, Los Alamos, NM, 87544
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
147452275
Principal Investigator
 Michael Harris
 Senior Biologist
 (505) 379-2735
 harris@caldera-pharmaceuticals.com
Business Contact
 Benjamin Warner
Title: CEO/CSO
Phone: (505) 412-2345
Email: warner@caldera-pharmaceuticals.com
Research Institution
N/A
Abstract
This proposed work will generate a targeted phosphate ester hydrolysis catalyst for agent denial. This catalyst will be targeted by conjugation to single stranded DNA. Characteristics of the catalyst will be determined, including ruggedness, targeting selectivity, and potential methods for deployment.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government